Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures

BACKGROUND: The goal of this study was to identify a clinical biomarker signature of brain amyloidosis in the Alzheimer's Disease Neuroimaging Initiative 1 (ADNI1) mild cognitive impairment (MCI) cohort. METHODS: We developed a multimodal biomarker classifier for predicting brain amyloidosis us...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Apostolova, Liana G., Hwang, Kristy S., Avila, David, Elashoff, David, Kohannim, Omid, Teng, Edmond, Sokolow, Sophie, Jack, Clifford R., Jagust, William J., Shaw, Leslie, Trojanowski, John Q., Weiner, Michael W., Thompson, Paul M.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4336101/
https://ncbi.nlm.nih.gov/pubmed/25609767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001231
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados